New HIV drug first to target CCR5 receptor

Article

A drug with a new mechanism of action is always a welcome addition in the fight against HIV. Maraviroc was recently approved by the FDA and is the first of the chemokine receptor 5 antagonists to enter the market.

Related Videos
fake news misinformation | Image Credit: Bits and Splits - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.